Federal Register Notice: FDA is making available Guidance for the Public, FDA Advisory Committee Members, and FDA Staff: Public Availability of Advisory Committee Members' Financial Interest Information and Waivers. It aims to make the public aware of the information available on certain financial interests and waivers granted by FDA to permit individuals to participate in an advisory committee meeting. The document provides additional transparency to FDA’s advisory committee process beyond current guidance. It finalizes the draft guidance of the same title dated 3/2010. To download this guidance, click here. To view this notice, click here.